Related Experiment Videos
High bone mass in mice expressing a mutant LRP5 gene
Philip Babij1, Weiguang Zhao, Clayton Small
1Genomics, Wyeth Research, Andover, Massachusetts, USA.
Summary
A specific mutation in the LRP5 gene leads to high bone mass and strength in mice. This discovery highlights LRP5
Area of Science:
- Molecular Biology
- Genetics
- Bone Biology
- Skeletal Physiology
Background:
- A specific mutation (G171V) in the low-density lipoprotein receptor related protein 5 (LRP5) gene has been identified in humans with high bone mass (HBM).
- LRP5 plays a crucial role in skeletal regulation, but the precise mechanisms underlying its influence on bone density and strength are still being investigated.
Purpose of the Study:
- To validate the role of the LRP5 G171V mutation in skeletal regulation.
- To investigate the effects of this mutation on bone mineral density, bone structure, and biomechanical properties in a transgenic mouse model.
Main Methods:
- Generation of transgenic mice expressing either the human LRP5 G171V mutation or the wildtype LRP5 gene in bone.
- Quantitative computed tomography (pQCT) and high-resolution microcomputed tomography (microCT) for bone mineral density and structural analysis.
- Biomechanical testing for vertebral compressive and femoral bending strength.
- Histological analysis including osteoclast counting, alkaline phosphatase staining, and TUNEL assays.
Main Results:
- Transgenic mice with the LRP5 G171V mutation exhibited significantly increased volumetric bone mineral density (vBMD) and cortical size compared to wildtype controls.
- MicroCT analysis revealed substantial increases in trabecular bone volume fraction, number, and thickness in mutant mice.
- Mutant mice demonstrated enhanced vertebral compressive and femoral bending strength, with no change in osteoclast numbers but increased osteoblast activity and lifespan.
Conclusions:
- The LRP5 G171V mutation is sufficient to induce a high bone mass phenotype with enhanced skeletal strength in mice.
- The observed effects are primarily due to increased osteoblast number and activity, potentially linked to an extended functional lifespan, rather than altered osteoclastogenesis.
- These findings underscore the critical role of LRP5 in bone mass regulation and provide a valuable model for studying bone diseases and potential therapeutic targets.